Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

EMBO Molecular Medicine

Rhonda Sin‐Ling Chee¹  Nicholas Kim‐Wah Yeo¹  Zi Wei Chang¹  Siti Naqiah Amrun¹  Yi‐Hao Chan¹  Yun Shan Goh¹  Matthew Zirui Tay¹  Siew‐Wai Fong¹  Guillaume Carissimo¹  Chek‐Meng Poh¹  Laurent Renia¹  Cheryl Yi‐Pin Lee¹  Anthony Torres‐Ruesta²  Lisa F P Ng³  Seow‐Yen Tan⁴  Shirin Kalimuddin⁵  Barnaby Edward Young⁶  Yee‐Sin Leo⁷  David Chien Lye⁸  Wen‐Hsin Lee⁹  Bei Wang⁹  Olaf Rötzschke⁹  Bernett Lee⁹  Jackwee Lim⁹  Cheng‐I Wang⁹  Weili Xu⁹ 

[1] A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore City, Singapore;Singapore Immunology Network, Agency for Science, Technology and Research, Singapore City, Singapore;A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore City, Singapore;Singapore Immunology Network, Agency for Science, Technology and Research, Singapore City, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore;A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore City, Singapore;Singapore Immunology Network, Agency for Science, Technology and Research, Singapore City, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore;Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, Liverpool, UK;Department of Infectious Diseases, Changi General Hospital, Singapore City, Singapore;Department of Infectious Diseases, Singapore General Hospital, Singapore City, Singapore;Emerging Infectious Diseases Program, Duke‐NUS Medical School, Singapore City, Singapore;National Centre for Infectious Diseases, Singapore City, Singapore;Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore City, Singapore;Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore;National Centre for Infectious Diseases, Singapore City, Singapore;Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore City, Singapore;Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore;Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore;Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore;National Centre for Infectious Diseases, Singapore City, Singapore;Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore City, Singapore;Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore;Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore;Singapore Immunology Network, Agency for Science, Technology and Research, Singapore City, Singapore;

关键词: asymptomatic;    COVID‐19;    disease tolerance;    SARS‐CoV‐2;   

DOI  :  10.15252/emmm.202114045

来源: Wiley

【 授权许可】

CC BY